Aequus Pharmaceuticals Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was CAD 0.013359 million compared to CAD 0.347923 million a year ago. Net loss was CAD 0.803653 million compared to CAD 0.500471 million a year ago. Basic loss per share from continuing operations was CAD 0.01.
For the nine months, revenue was CAD 0.204019 million compared to CAD 0.996697 million a year ago. Net loss was CAD 2.25 million compared to CAD 2.19 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.